enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
10.60
-0.03 (-0.28%)
At close: Jul 31, 2026, 4:00 PM EDT
10.33
-0.27 (-2.55%)
After-hours: Jul 31, 2026, 4:10 PM EDT

enVVeno Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-16.75-20.9-23.83-25.24-24.93-16.89
Net Income
-15.72-19.47-21.82-23.52-24.67-16.53
Earnings Per Share
-25.07-33.06-44.53-66.85-77.00-66.50
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
21.4928.2143.1546.4139.0454.73
Total Debt
0.510.71.061.41.722.01
Net Cash (Debt)
20.9827.5142.0945.0137.3352.72
Net Cash Growth
-38.76%-34.63%-6.49%20.58%-29.20%523.64%
Net Cash Per Share
33.3346.7185.90128.07116.34212.59

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.62-15.57-16.84-18.86-15.62-11.85
Capital Expenditures
0-0.01-0.04-0.03-0.12-0.37
Free Cash Flow
-14.62-15.57-16.88-18.89-15.73-12.22
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.